ADAPTIMMUNE THERAPEUTICS PLC - AMERICAN DEPOSITARY
1.1100
17-5月-24 15:59:57
15 分の遅延
株式
-0.0900
-7.50%
本日の幅
1.1000 - 1.1750
ISIN
N/A
ソース
NASDAQ
-
Adaptimmune Announces Appointment of Joanna Brewer as Chief Scientific Officer
04 5 2022 08:00:00 提供 Nasdaq GlobeNewswire
-
Adaptimmune to Report Q1 2022 Financial Results and Business Updates on Monday, May 9, 2022
28 4 2022 16:30:00 提供 Nasdaq GlobeNewswire
-
08 4 2022 13:00:00 提供 Nasdaq GlobeNewswire
-
08 3 2022 12:35:58 提供 Nasdaq GlobeNewswire
-
Adaptimmune Announces Appointment of Cintia Piccina as Chief Commercial Officer
26 1 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
11 11 2021 09:00:00 提供 Nasdaq GlobeNewswire
-
Adaptimmune Reports Third Quarter Financial Results and Business Update
04 11 2021 07:30:01 提供 Nasdaq GlobeNewswire
-
Adaptimmune to Report Q3 2021 Financial Results and Business Update on Thursday, November 4, 2021
21 10 2021 08:00:01 提供 Nasdaq GlobeNewswire
-
Adaptimmune to Present Data Updates at Upcoming CTOS and SITC Meetings
05 10 2021 08:00:01 提供 Nasdaq GlobeNewswire
-
07 9 2021 07:00:02 提供 Nasdaq GlobeNewswire
-
Adaptimmune Updates Data from its Phase 1 Trial for Liver Cancer at ILCA Showing Clinical Benefit
05 9 2021 06:15:00 提供 Nasdaq GlobeNewswire
-
Adaptimmune Reports Second Quarter Financial Results and Business Update
09 8 2021 16:00:00 提供 Nasdaq GlobeNewswire
-
Adaptimmune to Report Q2 2021 Financial Results and Business Update on Monday, August 9, 2021
28 7 2021 08:11:31 提供 Nasdaq GlobeNewswire
-
19 5 2021 17:00:00 提供 Nasdaq GlobeNewswire
-
Adaptimmune Reports First Quarter Financial Results and Business Update
06 5 2021 07:30:01 提供 Nasdaq GlobeNewswire
-
Adaptimmune to Present First Preclinical Data from its HLA-independent TCR (HiT) Platform at ASGCT
27 4 2021 16:30:00 提供 Nasdaq GlobeNewswire
-
Adaptimmune to Report Q1 2021 Financial Results and Business Update on Thursday, May 6, 2021
22 4 2021 08:00:02 提供 Nasdaq GlobeNewswire